Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Post by desolationsoundon Feb 13, 2015 7:53am
137 Views
Post# 23425624

2015 Fiscal year end is Sept 30th for Microbix.

2015 Fiscal year end is Sept 30th for Microbix. Why is this important?
based on the Feb 12th update...

1) could have partner for Kinlytic signed before end of Sept for US and Canadian mrkts
2) LumiSort commercialization partner and funding agreement. Before end of Sept with field tests of commercial units early in fiscal 2016 which could translate to fall of 2015
3) patent trials on schedule for fall 2015 ?  The two parties could possibly settle before this goes to court  ......
    Which could mean a settlement some time earlier ....  iMHO

think they want to take the time to find the right companies to partner with for both LumiSort and Kinlytic. I think that  the demo trials of the LumiSort prototype went well and now they are negotiating with a few potential partners to build the commercial products with...
so maybe a good time to accumulate more stock now as we could be seeing some major news announcements over the next  2 to 6 months I think ...
Bullboard Posts